OPINION ARTICLE published : 07 January 2014 doi : 10 . 3389 / fcimb . 2013 . 00115 Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer Panayiota Markou and Yiorgos Apidianakis * Department of Biological Sciences , University of Cyprus , Nicosia , Cyprus * Correspondence : apidiana @ ucy . ac . cy Edited by : Dominique Ferrandon , Centre National de la Recherche Scientiﬁque , France Reviewed by : John C . Alverdy , University of Chicago , USA Keywords : inﬂammation , tumour , Drosophila , human , gut , epithelial damage , regeneration In 1882 , Robert Koch suggested four pos - tulates that establish causation between an infectious agent and a particular dis - ease : ( 1 ) the infectious organism must be found in abundance in all diseased , but not in healthy , organisms , ( 2 ) the infec - tious organism must be isolated from the diseased host and grown in culture , ( 3 ) the disease must be reproduced when the cultured organism is introduced into a healthy organism and ( 4 ) the same organ - ism must be reisolated from the exper - imentally diseased host ( Tabrah , 2011 ; Breitschwerdt et al . , 2013 ) . In Figure 1 we suggest an adaptation to the original pos - tulates of Koch to be used as a framework to assess the causation between intestinal Pseudomonas aeruginosa and intestinal dis - ease in patients with cancer . In the follow - ing sections we describe the prevalence of P . aeruginosa in cancer and the immuno - suppressive and stress - inducing condi - tions of cancer that facilitate the growth , dissemination and virulence of intestinal P . aeruginosa . In addition , we describe work showing that P . aeruginosa promotes intestinal epithelium cancer - related phe - notypes when introduced in tumor prone model hosts . CANCER AND OTHER IMMUNOSUPPRESSIVE CONDITIONS PROMOTE THE PREVALENCE OF P . aeruginosa Bacteremia is a major cause of life - threatening complications in patients with cancer , especially those who receive anti - cancer chemotherapy . Cancer patients are more vulnerable to invasive infec - tion , due to ulcerative lesions in mucosal surfaces and immune suppression sec - ondary to chemotherapy ( Safdar and Armstrong , 2001 ) . Many studies asso - ciate bloodstream infections in cancer patients with Gram - negative bacteria ( Oliveira et al . , 2007 ; Bos et al . , 2013 ; Montassier et al . , 2013 ) . P . aeruginosa is a Gram - negative opportunistic bacterium that causes various infections . Common community - acquired infections with P . aeruginosa are skin and soft tissue infections , ulcerative keratitis and otitis externa , while hospital - acquired infections include bloodstream infections , pneumonias and urinary tract infections ( Driscoll et al . , 2007 ) . Infections may be associated with a high rate of morbidity and mortality in immunocom - promised hosts , such as those suffering from chemotherapy - induced neutrope - nia , patients with cystic ﬁbrosis or severe burns and individuals who receive inten - sive care ( Driscoll et al . , 2007 ; Kerr and Snelling , 2009 ; Worth and Slavin , 2009 ; Stuart et al . , 2010 ; Raﬂa and Tredget , 2011 ) . P . aeruginosa intestinal carriage increases from ∼ 3 % in normal people to ∼ 20 % in hospitalized patients ( Stoodley and Thom , 1970 ) . In a case - control study the intestinal colonization by P . aeruginosa in cancer patients was 10 % before and 31 % after hospitalization ( Andremont et al . , 1989 ) . Studies conducted in oncology – hematology units , found an overall intestinal carriage of P . aeruginosa between 11 . 7 and 37 % ( Thuong et al . , 2003 ) . In another case - control study P . aeruginosa intestinal colonization was identiﬁed in 17 % of controls and 60 % of blood can - cer patients ( Vuotto et al . , 2013 ) . These epidemiology data suggest that intestinal colonization by P . aeruginosa is promi - nent among hospitalized cancer patients ( Andremont et al . , 1989 ; Vuotto et al . , 2013 ) . The intestinal carriage of P . aeruginosa is likely a consequence of the opportunistic nature of this species . Most P . aeruginosa infections appear secondary to a breach in host defences . In addition to compromised host immunity , intestinal microbiota play a major role in intestinal defence to infec - tion ( Levison , 1973 ) . Thus systemic expo - sure to antibiotics , which alters intestinal microbiota by reducing the abundance of certain microbes creates the opportunity for intestinal growth of P . aeruginosa and other pathogenic bacteria ( Hentges et al . , 1985 ) . INTESTINAL P . aeruginosa AS A SOURCE OF SYSTEMIC AND REMOTE INFECTIONS The translocation of endogenous intesti - nal P . aeruginosa extraluminally is an important pathogenic phenomenon and a cause of systemic infections , especially in neutropenic patients with hematolog - ical malignancies ( Okuda et al . , 2010 ) . During the translocation process , bacte - ria and their products cross the intestinal barrier by traveling between or through the cells of the intestinal epithelium , caus - ing infection and massive inﬂammation ( Alexander et al . , 1990 ; Papoff et al . , 2012 ) . Lung infections caused by P . aeruginosa are frequent in patients and can occur by direct contamination of the lungs by gas - trointestinal ﬂora or through hematoge - nous spread from the intestine to the lungs . Sepsis and mortality in immuno - compromised patients are the results of the presence of highly virulent strains of P . aeruginosa within the intestinal tract and the pathogen’s ability to adhere to the Frontiers in Cellular and Infection Microbiology www . frontiersin . org January 2014 | Volume 3 | Article 115 | 1 CELLULAR AND INFECTION MICROBIOLOGY Markou and Apidianakis Pseudomonas aeruginosa in cancer FIGURE 1 | An adaptation of Koch’s postulates assessing causation between intestinal P . aeruginosa and disease in patients with cancer . Studies using Drosophila and mammalian hosts may assess the role of P . aeruginosa in facilitating intestinal disease , including intestinal P . aeruginosa growth , dissemination , virulence and tumorigenesis , in predisposed hosts . In addition , clinical studies can be designed to assess the presence of P . aeruginosa in cancer patients and its role in intestinal disease , including tumorigenesis for which clinical data are lacking . intestinal epithelial barrier ( Marshall et al . , 1993 ; Alverdy et al . , 2000 ; Osmon et al . , 2004 ; Zaborina et al . , 2006 ; Okuda et al . , 2010 ) . P . aeruginosa uses different virulence factors that can damage epithelial cells , such as enzymes ( proteases and elastases ) , toxins , adhesins , ﬂagella and protein secre - tion systems ( Sundin et al . , 2004 ) . The T3SS enables the injection of at least four effector proteins ( ExoS , ExoT , ExoU , and ExoY ) into the host cell . ExoS injected into the host epithelial cell migrates to the membrane where it binds to the mam - malian factor FXYD3 , expressed speciﬁ - cally in the colon and stomach ( Okuda et al . , 2010 ) . Thus , ExoS may assist the penetration of P . aeruginosa through the intestinal epithelial barrier , impair - ing the defence function of tight junc - tions against bacterial penetration ( Okuda et al . , 2010 ) . Moreover , gut inﬂammation and apoptosis – which can be initiated by the Pseudomonas quinolone signal ( PQS ) – lead to tight junction disruption and an increase of epithelial barrier permeability ( Alverdy et al . , 2005 ; An , 2008 ) . Similarly , P . aeruginosa lectin PA - I , which is associ - ated with adhesion to epithelial cell layer , is produced after intestinal ischemia and secreted into the intestinal lumen , caus - ing tight junction interruption , epithelial barrier dysfunction and increase of its per - meability ( Seal et al . , 2011 ) . INTESTINAL P . aeruginosa EXHIBITS ENHANCED VIRULENCE UPON STRESS , SURGERY , TRAUMA , AND MAYBE CANCER Cohort studies show that infections are more frequent , severe and lethal among surgical patients ( Craven et al . , 1988 ; Sax et al . , 2011 ) . Surgical injury can shift the dynamics of the host - pathogen interaction leading to phenotype trans - formation or phase variation that devel - ops as microbes adapt and respond to novel environments , causing mor - bidity and mortality ( Babrowski et al . , 2013 ) . P . aeruginosa escalates its viru - lence and promotes systemic inﬂamma - tion during various conditions of host stress ( Seal et al . , 2011 ) . In patients col - onized by P . aeruginosa , the prolonged surgical injury releases stress - related host factors that can trigger the otherwise dormant colonizers , making them inva - sive and lethal ( Babrowski et al . , 2013 ) . Defence mechanisms such as degrada - tive proteases and lipases , exopolysaccha - ride capsule and outer membrane - derived vesicles ( OMVs ) , which serve as a secre - tion mechanism for virulence factors , Frontiers in Cellular and Infection Microbiology www . frontiersin . org January 2014 | Volume 3 | Article 115 | 2 Markou and Apidianakis Pseudomonas aeruginosa in cancer help the pathogen to survive in the host environment ( Macdonald and Kuehn , 2013 ) . OMVs are induced in response to physiological stressors and secreted dur - ing infection serving multiple roles in bacterial pathogenesis ( Macdonald and Kuehn , 2013 ) . In surgically stressed hosts interferon - gamma , endogenous opioids and the hypoxic end - products adenosine and inosine are released into the intesti - nal lumen where they bind bacteria and activate the expression of PA - I lectin and other virulence factors of P . aeruginosa . The PA - I lectin alters the tight junction permeability of the intestinal epithelium to exotoxin A , leading to lethal gut derived sepsis ( Long et al . , 2008 ) . Moreover , local intestinal depletion of extracellular phos - phate ( hypophosphatemia ) , which occurs after surgical injury , can activate virulent pathways due to bacterial sensing of low phosphate , shifting the phenotype of P . aeruginosa to that of a lethal strain ( Long et al . , 2008 ) . Because interferon - gamma , opioids and hypoxia are part of the host response and the therapeutic regiments administered to cancer patients ( Dunn et al . , 2005 ; Vaupel and Mayer , 2007 ) , the conditions that accompany cancer may also provide the signals for P . aeruginosa virulence induction . CAN P . aeruginosa SIMILARLY TO OTHER GASTROINTESTINAL BACTERIA FACILITATE CANCER ? Bacteria may initiate oncogenesis because they can induce inﬂammation and pro - duce cell damaging toxins that facili - tate tumorigenesis ( Collins et al . , 2011 ; Tjalsma et al . , 2012 ) . The characteristic single polar ﬂagella and type 4 pili of P . aeruginosa function as initiators of inﬂam - mation and adhesins , respectively ( Gellatly and Hancock , 2013 ) . P . aeruginosa induces Toll - like receptors to activate cytokines , chemokines and COX - 2 and recruit cells of the innate and adaptive immune sys - tem ( Hussain et al . , 2003 ; Holt et al . , 2008 ; de Lima et al . , 2012 ) . Epithelial adherence is a property of various bac - teria associated with gastrointestinal dis - ease and cancer , such as Bacteroides frag - ilis , Streptococcus bovis , Escherichia coli and Helicobacter pylori ( Toprak et al . , 2006 ; Selgrad et al . , 2008 ; Abdulamir et al . , 2011 ; Arthur et al . , 2012 ) . Cell wall antigens of S . bovis induce overexpression of COX - 2 and NF - κ B in vitro , which promote cellular proliferation and angiogenesis ( Tafe and Ruoff , 2007 ; Abdulamir et al . , 2009 ) . E - cadherin , a cell adhesion molecule serves as an antagonist of invasion and metastasis and is found mutated in human carcinomas ( Cavallaro and Christofori , 2004 ; Berx and van Roy , 2009 ) . B . frag - ilis secreted factor BFT cleaves E - cadherin , which is usually bound inside the plasma membrane to β - catenin . The cleavage releases catenin in the cytosol leading to the transcription of the oncogene c - myc ( Hardy et al . , 2000 ) . Similarly , P . aerug - inosa secreted factor LasI can disrupt adherens junctions and reduce the expres - sion and distribution of E - cadherin and β - catenin in the cell membrane , result - ing in changes in cell junction associations and enhanced paracellular permeability ( Vikström et al . , 2009 ) . Interestingly , intestinal innate immune responses and stem cells may drive tumor initiation , maintenance and metastasis ( Schwitalla et al . , 2013 ) . Cancer develop - ment is assisted by apoptotic programmed cell death in the tumor microenviron - ment ( Evan and Littlewood , 1998 ; Lowe et al . , 2004 ; Adams and Cory , 2007 ) and P . aeruginosa uses many virulence factors that induce epithelial cell apop - tosis . Intestinal infection with P . aerug - inosa in Drosophila activates the c - Jun N - terminal kinase ( JNK ) pathway , which causes apoptosis of enterocytes and leads to proliferation of intestinal stem cells ( Apidianakis et al . , 2009 ) . Importantly , genetic predisposition via an oncogenic form of Ras1 / K - Ras oncogene , can syner - gize with inﬂammatory signals to induce stem cell - originating tumors character - ized by alterations in cell polarity and tissue architecture . Moreover , sustained intestinal infection with P . aeruginosa in Drosophila induces the Imd / NF - κ B path - way , which synergizes with the oncogene Ras1 V 12 to activate the JNK pathway . This leads to invasion and dissemina - tion of oncogenic hindgut cells to dis - tant sites ( Bangi et al . , 2012 ; Christoﬁ and Apidianakis , 2013 ) . CONCLUSIONS P . aeruginosa is a common colonizer of the human intestine upon hospi - talization , immunosuppression , antibiotic treatment , surgery , severe trauma and other conditions that cancer patients may face . Not only is P . aeruginosa car - riage increased in the aforementioned conditions , but also bacteria become more virulent and damaging to the intesti - nal epithelium upon surgery , injury , and severe stress . Moreover , human isolates of P . aeruginosa can induce intestinal pathol - ogy and cancer - related epithelial pheno - types in genetically predisposed model hosts . Thus , P . aeruginosa appears to have the opportunity and the ability to promote intestinal disease in predisposed hosts , although further proof on the ability of this bacterium to promote tumorigenesis in mammalian models of infection is needed . The lack of epidemiological data linking P . aeruginosa to intestinal disease and potentially tumorigenesis in cancer patients may reﬂect the lack of clinical studies assessing bacterial growth and vir - ulence in relation to cancer recurrence . Because the titter , distribution and vir - ulence of P . aeruginosa in the intestine may be very dynamic ( Tjalsma et al . , 2012 ) , future studies should be designed to repeatedly assess intestinal P . aerug - inosa abundance and virulence in can - cer patients versus healthy individuals . Clinical samples can be assessed for the presence of P . aeruginosa via clas - sical microbiology , and next - generation sequencing may offer the chance to assess P . aeruginosa transcriptome during infec - tion . Importantly , deﬁnite proof of cau - sation of P . aeruginosa in morbidity and mortality of cancer patients can only be achieved if targeted elimination of P . aeruginosa from these patients improves the outcome of their disease . In Figure 1 we illustrate a roadmap to speciﬁcally assess the role of P . aeruginosa in intestinal disease and tumorigenesis . It is conceiv - able that similar principles can be used to assess causality between intestinal disease and many other opportunistic pathogens harbored by the human gut . REFERENCES Abdulamir , A . S . , Haﬁdh , R . R . , and Abu Bakar , F . ( 2011 ) . The association of streptococcus bovis / gallolyticus with colorectal tumors : the nature and the underlying mechanisms of its etiological role . J . Exp . Clin . Cancer Res . 30 , 11 . doi : 10 . 1186 / 1756 - 9966 - 30 - 11 Abdulamir , A . S . , Haﬁdh , R . R . , Mahdi , L . K . , Al - jeboori , T . , and Abubaker , F . ( 2009 ) . Investigation into the controversial associa - tion of streptococcus gallolyticus with colorectal Frontiers in Cellular and Infection Microbiology www . frontiersin . org January 2014 | Volume 3 | Article 115 | 3 Markou and Apidianakis Pseudomonas aeruginosa in cancer cancer and adenoma . BMC Cancer 9 : 403 . doi : 10 . 1186 / 1471 - 2407 - 9 - 403 Adams , J . M . , and Cory , S . ( 2007 ) . The bcl - 2 apoptotic switch in cancer development and therapy . Oncogene 26 , 1324 – 1337 . doi : 10 . 1038 / sj . onc . 1210220 Alexander , J . W . , Boyce , S . T . , Babcock , G . F . , Gianotti , L . , Peck , M . D . , Dunn , D . L . , et al . ( 1990 ) . The process of microbial translocation . Ann . Surg . 212 , 496 – 510 . discussion : 511 – 512 . doi : 10 . 1097 / 00000658 - 199010000 - 00012 Alverdy , J . , Holbrook , C . , Rocha , F . , Seiden , L . , Wu , R . L . , Musch , M . , et al . ( 2000 ) . Gut - derived sepsis occurs when the right pathogen with the right virulence genes meets the right host : evidence for in vivo virulence expression in Pseudomonas aeruginosa . Ann . Surg . 232 , 480 – 489 . doi : 10 . 1097 / 00000658 - 200010000 - 00003 Alverdy , J . , Zaborina , O . , and Wu , L . ( 2005 ) . The impact of stress and nutrition on bacterial - host interactions at the intestinal epithelial surface . Curr . Opin . Clin . Nutr . Metab . Care 8 , 205 – 209 . doi : 10 . 1097 / 00075197 - 200503000 - 00016 An , G . ( 2008 ) . Introduction of an agent - based multi - scale modular architecture for dynamic knowledge representation of acute inﬂammation . Theor . Biol . Med . Model . 5 , 11 . doi : 10 . 1186 / 1742 - 4682 - 5 - 11 Andremont , A . , Marang , B . , Tancrede , C . , Baume , D . , and Hill , C . ( 1989 ) . Antibiotic treatment and intestinal colonization by Pseudomonas aeruginosa in cancer patients . Antimicrob . Agents Chemother . 33 , 1400 – 1402 . doi : 10 . 1128 / AAC . 33 . 8 . 1400 Apidianakis , Y . , Pitsouli , C . , Perrimon , N . , and Rahme , L . ( 2009 ) . Synergy between bacterial infection and genetic predisposition in intesti - nal dysplasia . Proc . Natl . Acad . Sci . U . S . A . 106 , 20883 – 20888 . doi : 10 . 1073 / pnas . 0911797106 Arthur , J . C . , Perez - Chanona , E . , Mühlbauer , M . , Tomkovich , S . , Uronis , J . M . , Fan , T . J . , et al . ( 2012 ) . Intestinal inﬂammation targets cancer - inducing activity of the microbiota . Science 338 , 120 – 123 . doi : 10 . 1126 / science . 1224820 Babrowski , T . , Romanowski , K . , Fink , D . , Kim , M . , Gopalakrishnan , V . , Zaborina , O . , et al . ( 2013 ) . The intestinal environment of surgical injury transforms Pseudomonas aeruginosa into a dis - crete hypervirulent morphotype capable of caus - ing lethal peritonitis . Surgery 153 , 36 – 43 . doi : 10 . 1016 / j . surg . 2012 . 06 . 022 Bangi , E . , Pitsouli , C . , Rahme , L . G . , Cagan , R . , and Apidianakis , Y . ( 2012 ) . Immune response to bacteria induces dissemination of ras - activated drosophila hindgut cells . EMBO Rep . 13 , 569 – 576 . doi : 10 . 1038 / embor . 2012 . 44 Berx , G . , and van Roy , F . ( 2009 ) . Involvement of members of the cadherin superfamily in cancer . Cold Spring Harb . Perspect . Biol . 1 , a003129 . doi : 10 . 1101 / cshperspect . a003129 Bos , M . M . , Smeets , L . S . , Dumay , I . , and de Jonge , E . ( 2013 ) . Bloodstream infections in patients with or without cancer in a large community hospital . Infection 41 , 949 – 988 . doi : 10 . 1007 / s15010 - 013 - 0468 - 1 Breitschwerdt , E . B . , Linder , K . L . , Day , M . J . , Maggi , R . G . , Chomel , B . B . , and Kempf , V . A . ( 2013 ) . Koch’s postulates and the pathogenesis of compar - ative infectious disease causation associated with bartonella species . J . Comp . Pathol . 148 , 115 – 125 . doi : 10 . 1016 / j . jcpa . 2012 . 12 . 003 Cavallaro , U . , and Christofori , G . ( 2004 ) . Cell adhe - sion and signalling by cadherins and ig - CAMs in cancer . Nat . Rev . Cancer 4 , 118 – 132 . doi : 10 . 1038 / nrc1276 Christoﬁ , T . , and Apidianakis , Y . ( 2013 ) . Ras - oncogenic drosophila hindgut but not midgut cells use an inﬂammation - like program to dissemi - nate to distant sites . Gut Microbes 4 , 54 – 59 . doi : 10 . 4161 / gmic . 22429 Collins , D . , Hogan , A . M . , and Winter , D . C . ( 2011 ) . Microbial and viral pathogens in colorectal cancer . Lancet Oncol . 12 , 504 – 512 . doi : 10 . 1016 / S1470 - 2045 ( 10 ) 70186 - 8 Craven , D . E . , Kunches , L . M . , Lichtenberg , D . A . , Kollisch , N . R . , Barry , M . A . , Heeren , T . C . , et al . ( 1988 ) . Nosocomial infection and fatality in med - ical and surgical intensive care unit patients . Arch . Intern . Med . 148 , 1161 – 1168 . doi : 10 . 1001 / arch - inte . 1988 . 00380050165024 de Lima , C . D . M . , Calegari - Silva , T . C . , Pereira , R . M . S . , de Oliveira Lima Santos , S . A . , Lopes , U . G . , Plotkowski , M . C . M . , et al . ( 2012 ) . ExoU activates NF - κ B and increases IL - 8 / KC secre - tion during Pseudomonas aeruginosa infection . PLoS ONE 7 : e41772 . doi : 10 . 1371 / journal . pone . 0041772 Driscoll , J . A . , Brody , S . L . , and Kollef , M . H . ( 2007 ) . The epidemiology , pathogenesis and treat - ment of Pseudomonas aeruginosa infections . Drugs 67 , 351 – 368 . doi : 10 . 2165 / 00003495 - 200767030 - 00003 Dunn , G . P . , Ikeda , H . , Bruce , A . T . , Koebel , C . , Uppaluri , R . , Bui , J . , et al . ( 2005 ) . Interferon - gamma and cancer immunoediting . Immunol . Res . 32 , 231 – 245 . doi : 10 . 1385 / IR : 32 : 1 - 3 : 231 Evan , G . , and Littlewood , T . ( 1998 ) . A matter of life and cell death . Science 281 , 1317 – 1322 . doi : 10 . 1126 / science . 281 . 5381 . 1317 Gellatly , S . L . , and Hancock , R . E . ( 2013 ) . Pseudomonas aeruginosa : new insights into pathogenesis and host defenses . Pathog . Dis . 67 , 159 – 173 . doi : 10 . 1111 / 2049 - 632X . 12033 Hardy , R . G . , Meltzer , S . J . , and Jankowski , J . A . ( 2000 ) . ABC of colorectal cancer . Molecular basis for risk factors . BMJ 321 , 886 – 889 . doi : 10 . 1136 / bmj . 321 . 7265 . 886 Hentges , D . J . , Stein , A . J . , Casey , S . W . , and Que , J . U . ( 1985 ) . Protective role of intestinal ﬂora against infection with Pseudomonas aeruginosa in mice : inﬂuence of antibiotics on colonization resistance . Infect . Immun . 47 , 118 – 122 . Holt , P . G . , Strickland , D . H . , Wikstrom , M . E . , and Jahnsen , F . L . ( 2008 ) . Regulation of immuno - logical homeostasis in the respiratory tract . Nat . Rev . Immunol . 8 , 142 – 152 . doi : 10 . 1038 / nri2236 Hussain , S . P . , Hofseth , L . J . , and Harris , C . C . ( 2003 ) . Radical causes of cancer . Nat . Rev . Cancer 3 , 276 – 285 . doi : 10 . 1038 / nrc1046 Kerr , K . G . , and Snelling , A . M . ( 2009 ) . Pseudomonas aeruginosa : a formidable and ever - present adversary . J . Hosp . Infect . 73 , 338 – 344 . doi : 10 . 1016 / j . jhin . 2009 . 04 . 020 Levison , M . E . ( 1973 ) . Effect of colon ﬂora and short - chainfattyacidsongrowth invitro of Pseudomonas aeruginosa and enterobacteriaceae . Infect . Immun . 8 , 30 – 35 . Long , J . , Zaborina , O . , Holbrook , C . , Zaborin , A . , and Alverdy , J . ( 2008 ) . Depletion of intesti - nal phosphate after operative injury activates the virulence of P . aeruginosa causing lethal gut - derived sepsis . Surgery 144 , 189 – 197 . doi : 10 . 1016 / j . surg . 2008 . 03 . 045 Lowe , S . W . , Cepero , E . , and Evan , G . ( 2004 ) . Intrinsic tumour suppression . Nature 432 , 307 – 315 . doi : 10 . 1038 / nature03098 Macdonald , I . A . , and Kuehn , M . J . ( 2013 ) . Stress - induced outer membrane vesicle production by Pseudomonas aeruginosa . J . Bacteriol . 195 , 2971 – 2981 . doi : 10 . 1128 / JB . 02267 - 12 Marshall , J . C . , Christou , N . V . , and Meakins , J . L . ( 1993 ) . The gastrointestinal tract . The “undrained abscess” of multiple organ failure . Ann . Surg . 218 , 111 – 119 . doi : 10 . 1097 / 00000658 - 199308000 - 00001 Montassier , E . , Batard , E . , Gastinne , T . , Potel , G . , and de La Cochetiere , M . F . ( 2013 ) . Recent changes in bacteremia in patients with cancer : a systematic review of epidemiology and antibiotic resistance . Eur . J . Clin . Microbiol . Infect . Dis . 32 , 841 – 850 . doi : 10 . 1007 / s10096 - 013 - 1819 - 7 Okuda , J . , Hayashi , N . , Okamoto , M . , Sawada , S . , Minagawa , S . , Yano , Y . , et al . ( 2010 ) . Translocation of Pseudomonas aeruginosa from the intesti - nal tract is mediated by the binding of ExoS to an na , K - ATPase regulator , FXYD3 . Infect . Immun . 78 , 4511 – 4522 . doi : 10 . 1128 / IAI . 00428 - 10 Oliveira , A . L . , de Souza , M . , Carvalho - Dias , V . M . , Ruiz , M . A . , Silla , L . , Tanaka , P . Y . , et al . ( 2007 ) . Epidemiology of bacteremia and factors associ - ated with multi - drug - resistant gram - negative bac - teremia in hematopoietic stem cell transplant recipients . Bone Marrow Transplant . 39 , 775 – 781 . doi : 10 . 1038 / sj . bmt . 1705677 Osmon , S . , Ward , S . , Fraser , V . J . , and Kollef , M . H . ( 2004 ) . Hospital mortality for patients with bacteremia due to staphylococcus aureus or Pseudomonas aeruginosa . Chest 125 , 607 – 616 . doi : 10 . 1378 / chest . 125 . 2 . 607 Papoff , P . , Ceccarelli , G . , d’Ettorre , G . , Cerasaro , C . , Caresta , E . , Midulla , F . , et al . ( 2012 ) . Gut microbial translocation in critically ill children and effects of supplementation with pre - and pro biotics . Int . J . Microbiol . 2012 , 151393 . doi : 10 . 1155 / 2012 / 151393 Raﬂa , K . , and Tredget , E . E . ( 2011 ) . Infection con - trol in the burn unit . Burns 37 , 5 – 15 . doi : 10 . 1016 / j . burns . 2009 . 06 . 198 Safdar , A . , and Armstrong , D . ( 2001 ) . Infectious morbidity in critically ill patients with can - cer . Crit . Care Clin . 17 , 531 – 570 , vii – viii . doi : 10 . 1016 / S0749 - 0704 ( 05 ) 70198 - 6 Sax , H . , Uckay , I . , Balmelli , C . , Bernasconi , E . , Boubaker , K . , Muhlemann , K . , et al . ( 2011 ) . Overall burden of healthcare - associated infec - tions among surgical patients . Results of a national study . Ann . Surg . 253 , 365 – 370 . doi : 10 . 1097 / SLA . 0b013e318202fda9 Schwitalla , S . , Fingerle , A . A . , Cammareri , P . , Nebelsiek , T . , Göktuna , S . I . , Ziegler , P . K . , et al . ( 2013 ) . Intestinal tumorigenesis initi - ated by dedifferentiation and acquisition of stem - cell - like properties . Cell 152 , 25 – 38 . doi : 10 . 1016 / j . cell . 2012 . 12 . 012 Frontiers in Cellular and Infection Microbiology www . frontiersin . org January 2014 | Volume 3 | Article 115 | 4 Markou and Apidianakis Pseudomonas aeruginosa in cancer Seal , J . B . , Alverdy , J . C . , Zaborina , O . , and An , G . ( 2011 ) . Agent - baseddynamicknowledgerepresen - tation of Pseudomonas aeruginosa virulence acti - vation in the stressed gut : towards characterizing host - pathogen interactions in gut - derived sepsis . Theor . Biol . Med . Model . 8 , 33 . doi : 10 . 1186 / 1742 - 4682 - 8 - 33 Selgrad , M . , Malfertheiner , P . , Fini , L . , Goel , A . , Boland , C . R . , and Ricciardiello , L . ( 2008 ) . The role of viral and bacterial pathogens in gastroin - testinal cancer . J . Cell . Physiol . 216 , 378 – 388 . doi : 10 . 1002 / jcp . 21427 Stoodley , B . J . , and Thom , B . T . ( 1970 ) . Observations on the intestinal carriage of Pseudomonas aeruginosa . J . Med . Microbiol . 3 , 367 – 375 . doi : 10 . 1099 / 00222615 - 3 - 3 - 367 Stuart , B . , Lin , J . H . , and Mogayzel , P . J . Jr . ( 2010 ) . Early eradication of Pseudomonas aeruginosa in patients with cystic ﬁbrosis . Paediatr . Respir . Rev . 11 , 177 – 184 . doi : 10 . 1016 / j . prrv . 2010 . 05 . 003 Sundin , C . , Thelaus , J . , Broms , J . E . , and Forsberg , A . ( 2004 ) . Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG , PcrV and PopN . Microb . Pathog . 37 , 313 – 322 . doi : 10 . 1016 / j . micpath . 2004 . 10 . 005 Tabrah , F . L . ( 2011 ) . Koch’s postulates , carnivorous cows , and tuberculosis today . Hawaii Med . J . 70 , 144 – 148 . Tafe , L . J . , and Ruoff , K . L . ( 2007 ) . Streptococcus bovis : answers and questions . Clin . Microbiol . Newsl . 29 , 49 – 55 . doi : 10 . 1016 / j . clinmicnews . 2007 . 03 . 004 Thuong , M . , Arvaniti , K . , Ruimy , R . , de laSalmoniere , P . , Scanvic - Hameg , A . , Lucet , J . C . , et al . ( 2003 ) . Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an inten - sive care unit . J . Hosp . Infect . 53 , 274 – 282 . doi : 10 . 1053 / jhin . 2002 . 1370 Tjalsma , H . , Boleij , A . , Marchesi , J . R . , and Dutilh , B . E . ( 2012 ) . A bacterial driver – passenger model for colorectal cancer : beyond the usual suspects . Nat . Rev . Microbiol . 10 , 575 – 582 . doi : 10 . 1038 / nrmi - cro2819 Toprak , N . U . , Yagci , A . , Gulluoglu , B . M . , Akin , M . L . , Demirkalem , P . , Celenk , T . , et al . ( 2006 ) . A possible role of bacteroides fragilis enterotoxin in the aetiology of colorectal cancer . Clin . Microbiol . Infect . 12 , 782 – 786 . doi : 10 . 1111 / j . 1469 - 0691 . 2006 . 01494 . x Vaupel , P . , and Mayer , A . ( 2007 ) . Hypoxia in can - cer : signiﬁcance and impact on clinical out - come . Cancer Metastasis Rev . 26 , 225 – 239 . doi : 10 . 1007 / s10555 - 007 - 9055 - 1 Vikström , E . , Bui , L . , Konradsson , P . , and Magnusson , K . E . ( 2009 ) . The junctional integrity of epithelial cells is modulated by Pseudomonas aeruginosa quorum sensing molecule through phosphorylation - dependent mechanisms . Exp . Cell Res . 315 , 313 – 326 . doi : 10 . 1016 / j . yexcr . 2008 . 10 . 044 Vuotto , F . , Berthon , C . , Lemaitre , N . , Duhamel , A . , Balkaran , S . , Le Ray , E . , et al . ( 2013 ) . Risk factors , clinical features , and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies : a case - control study . Am . J . Infect . Control 41 , 527 – 530 . doi : 10 . 1016 / j . ajic . 2012 . 07 . 012 Worth , L . J . , and Slavin , M . A . ( 2009 ) . Bloodstream infections in haematology : risks and new challenges for prevention . Blood Rev . 23 , 113 – 122 . doi : 10 . 1016 / j . blre . 2008 . 10 . 003 Zaborina , O . , Kohler , J . E . , Wang , Y . , Bethel , C . , Shevchenko , O . , Wu , L . , etal . ( 2006 ) . Identiﬁcation of multi - drug resistant Pseudomonas aeruginosa clinical isolates that are highly disruptive to the intestinal epithelial barrier . Ann . Clin . Microbiol . Antimicrob . 5 , 14 . doi : 10 . 1186 / 1476 - 0711 - 5 - 14 Received : 26 September 2013 ; accepted : 22 December 2013 ; published online : 07 January 2014 . Citation : Markou P and Apidianakis Y ( 2014 ) Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer . Front . Cell . Infect . Microbiol . 3 : 115 . doi : 10 . 3389 / fcimb . 2013 . 00115 This article was submitted to the journal Frontiers in Cellular and Infection Microbiology . Copyright © 2014 Markou and Apidianakis . This is an open - access article distributed under the terms of the Creative Commons Attribution License ( CC BY ) . The use , distribution or reproduction in other forums is permitted , provided the original author ( s ) or licen - sor are credited and that the original publication in this journal is cited , in accordance with accepted academic practice . No use , distribution or reproduc - tion is permitted which does not comply with these terms . Frontiers in Cellular and Infection Microbiology www . frontiersin . org January 2014 | Volume 3 | Article 115 | 5